CAMP4 Therapeutics Revenue and Competitors

Boston, MA USA

Location

$90M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CAMP4 Therapeutics's estimated annual revenue is currently $14.4M per year.(i)
  • CAMP4 Therapeutics's estimated revenue per employee is $155,000
  • CAMP4 Therapeutics's total funding is $90M.

Employee Data

  • CAMP4 Therapeutics has 93 Employees.(i)
  • CAMP4 Therapeutics grew their employee count by -8% last year.

CAMP4 Therapeutics's People

NameTitleEmail/Phone
1
VP, BiologyReveal Email/Phone
2
SVP, Discovery & TranslationReveal Email/Phone
3
Associate Director, DiscoveryReveal Email/Phone
4
Associate Director, Lab Operations & FacilitiesReveal Email/Phone
5
Director Quality AssuranceReveal Email/Phone
6
Chief People OfficerReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Senior Director, Head Intellectual PropertyReveal Email/Phone
9
Associate Director, Head Discovery, CNSReveal Email/Phone
10
Director - PreclinicalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is CAMP4 Therapeutics?

Founded in 2016 and focused on a core mission of realizing a world with ‘an effective treatment option for every patient,’ CAMP4 Therapeutics evolved from seminal discoveries made by company founders Dr. Richard Young and Dr. Leonard Zon, characterizing the ways in which dynamic cell signaling networks control the expression of genes. Operating at the intersection of genomics, computational biology and data sciences, CAMP4 has extended this foundational work, creating a unique Gene Circuitry Platform to amplify the value of cellular and genetic insights to better understand how genes are controlled by signaling pathways in specific disease states. By generating proprietary 4D maps, CAMP4 can identify de-risked druggable targets, produce actionable insights and improve therapeutic predictability, potentially addressing hundreds of diseases and benefiting millions of patients globally. Find out more at www.camp4tx.com.

keywords:N/A

$90M

Total Funding

93

Number of Employees

$14.4M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CAMP4 Therapeutics News

2022-04-17 - Movers & Shakers: John Maraganore, Larry Alstiel, Brad Margus ...

CAMP4 Therapeutics: Kelly Gold was named CFO of CAMP4. Gold currently serves as the company's chief business officer and SVP of finance.

2022-04-17 - CFOs On the Move: Week Ending April 22

IMAX, Omni, Convoy, Beachbody, Celsius, CNN, CAMP4 Therapeutics, Splash Beverage Group, Lummus Technology, Truepill. Lauren MuskettApril 22,...

2022-04-17 - CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer

BUSINESS WIRE)--CAMP4 Therapeutics, a biotechnology company harnessing the power of regulatory RNAs to upregulate genes and restore healthy...

2021-06-15 - CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes

CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore healthy gene expression, today announced that it has raised $45 million to propel the next phase of its scientific strategy, significantly expand its platform and advance multiple preclinical RNA therapies into hu ...

2018-06-01 - Camp4 Therapeutics Raises $30M in Series A Financing

Camp4 Therapeutics, a Cambridge, MA-based platform to discover effective treatment approaches for every disease, raised $30M in Series A financing. The round was led by Andreessen Horowitz, with participation from Polaris Partners and The Kraft Group. The company intends to use the funds to ex ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.1M93-5%N/A
#2
$19.5M933%N/A
#3
$13M93-13%N/A
#4
$14.9M9341%N/A
#5
$15M93-7%N/A